Free Account Opening + AMC Free Demat
Loading...

Global Surfaces IPO vs Mankind Pharma IPO

Comparision between Global Surfaces IPO and Mankind Pharma IPO.

IPO Details

Global Surfaces IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mankind Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Global Surfaces IPO is up to ₹154.98 Cr whereas the issue size of the Mankind Pharma IPO is up to ₹4,326.36 Cr. The final issue price of Global Surfaces IPO is ₹140.00 per share and of Mankind Pharma IPO is ₹1,080.00 per share.

  Global Surfaces IPO Mankind Pharma IPO
Face Value ₹10 per share ₹1 per share
Issue Price (Lower) ₹133.00 per share ₹1,026.00 per share
Issue Price (Upper) ₹140.00 per share ₹1,080.00 per share
Issue Price (Final) ₹140.00 per share ₹1,080.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 100 shares 13 shares
Fresh Issue Size 85,20,000 shares
Fresh Issue Size (Amount) up to ₹119.28 Cr
OFS Issue Size 25,50,000 shares 4,00,58,844 shares
OFS Issue Size (Amount) up to ₹35.70 Cr up to ₹4,326.36 Cr
Issue Size Total 1,10,70,000 shares 4,00,58,844 shares
Issue Size Total (Amount) up to ₹154.98 Cr up to ₹4,326.36 Cr

IPO Timetable

Global Surfaces IPO opens on Mar 13, 2023, while Mankind Pharma IPO opens on Apr 25, 2023. The closing date of Global Surfaces IPO and Mankind Pharma IPO is Mar 15, 2023, and Apr 27, 2023, respectively.

  Global Surfaces IPO Mankind Pharma IPO
Anchor Bid Date Mar 10, 2023 Apr 24, 2023
Issue Open Mar 13, 2023 Apr 25, 2023
Issue Close Mar 15, 2023 Apr 27, 2023
Basis Of Allotment (Tentative) Mar 20, 2023 May 03, 2023
Initiation of Refunds (Tentative) Mar 21, 2023 May 04, 2023
Credit of Share (Tentative) Mar 22, 2023 May 05, 2023
Listing date (Tentative) Mar 23, 2023 May 09, 2023
Anchor Lockin End date 1 Apr 19, 2023 Jun 02, 2023
Anchor Lockin End date 2 Jun 18, 2023 Aug 01, 2023

Financials

Global Surfaces IPO P/E ratio is 21.84, as compared to Mankind Pharma IPO P/E ratio of 32.5.

  Global Surfaces IPO Mankind Pharma IPO
Financial
Global Surfaces Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-20128.73165.7820.9664.4858.0353.49
31-Mar-21159.00179.0033.9398.4391.9837.46
31-Mar-22236.48198.3635.63134.04100.1737.28
30-Sep-22280.2099.2513.59148.93115.0750.52
Amount in ₹ Crore
Mankind Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-205,073.295,975.651,056.153,485.313,436.34126.92
31-Mar-216,372.636,385.381,293.034,722.004,674.39234.53
31-Dec-218,043.886,218.291,260.245,965.465,916.86268.70
31-Mar-229,147.747,977.581,452.966,155.236,106.06868.03
31-Dec-229,273.756,777.821,015.987,145.897,094.12167.93
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 99.35% 79.00%
Promoter Shareholding (Post-Issue) 76.50%
P/E Ratio 21.84 32.5
Market Cap ₹593.35 Cr. ₹43263.60 Cr.
ROE 27.60%%
ROCE 26.10%%
Debt/Equity
EPS ₹33.20
RoNW 27.70%%

Shares Offered

In the Global Surfaces IPO retail investors (RII) are offered 38,74,500 shares while in Mankind Pharma IPO retail investors are offered 38,74,500 shares. Qualified institutional buyers (QIB) are offered 22,14,000 shares in Global Surfaces IPO and 80,11,769 shares in Mankind Pharma IPO.

  Global Surfaces IPO Mankind Pharma IPO
Anchor Investor Reserveration 33,21,000 shares 1,20,17,652 shares
Market Maker Reserveration
QIB 22,14,000 shares 80,11,769 shares
NII 16,60,500 shares 60,08,827 shares
RII 38,74,500 shares 1,40,20,596 shares
Employee 0 shares 0 shares
Others
Total 77,49,000 shares 2,80,41,192 shares

Bids Received (Subscription)

Global Surfaces IPO subscribed 12.21x in total, whereas Mankind Pharma IPO subscribed 15.32x.

  Global Surfaces IPO Mankind Pharma IPO
QIB (times) 8.95x 49.16x
NII (times) 33.10x 3.80x
Big NII (times) 35.00x 4.99x
Small NII (times) 29.29x 1.41x
RII (times) 5.12x 0.92x
Employee (times)
Other (times)
Total (times) 12.21x 15.32x

Comments

Add a public comment...